Skip to main content
logo
Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.810
-0.030 (-0.78%)
At close: Apr 14, 2026, 4:00 PM EDT
3.780
-0.030 (-0.79%)
After-hours: Apr 14, 2026, 5:25 PM EDT

Adagene Revenue

In the year 2025, Adagene had annual revenue of $7.67M with 7,332.76% growth. Adagene had revenue of $7.67M in the half year ending December 31, 2025, with 840.35% growth.

Revenue (ttm)
$7.67M
Revenue Growth
+7,332.76%
P/S Ratio
34.20
Revenue / Employee
$59,929
Employees
128
Market Cap
251.74M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.67M7.57M7,332.76%
Dec 31, 2024103.20K-18.01M-99.43%
Dec 31, 202318.11M8.82M94.90%
Dec 31, 20229.29M-882.53K-8.67%
Dec 31, 202110.18M9.47M1,351.71%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Arcturus Therapeutics Holdings82.03M
Compugen72.76M
Coherus Oncology42.17M
C4 Therapeutics35.95M
Orchestra BioMed Holdings33.48M
Alector21.05M
Sol-Gel Technologies19.39M
Camp4 Therapeutics3.50M
Revenue Rankings

ADAG News

More News